The role of Chlamydia trachomatis in the pathogenesis of Pelvic inflammatory disease and majority of cases of salpinigitis are well acknowledged in women. A total of 213 sera from infertile women were tested for antibodies to Chlamydia trachomatis by using an indirect solid phases enzyme Immuno absorbent commercial ELISA test. Women with confirmed Hysterosalpinographic report suggesting tubal occlusion (tubal factor infertility) had 92 (43.2%) followed by 63 (29.6%) infertile women with infertile male partner and 58 (27.2%) were having unexplained infertility. Out of the tubal factor (TF) infertile women 40 (18.8%) were seropositive for Chlamydia trachomatis antibodies, as against 19 (8.9%) in the group of women with normal patent tubes and 10 (4.6%) women with infertile male partner. In this study there was a statistical significant correlation between the infertile women with tubal factor infertility in relation to seroevidence of Chlamydia trachomatis infection with p<0.05. There was no age bias in the serodetection of Chlamydia trachomatis antibodies. The seropositivity of Chlamydia trachomatis is an indication that the organism may be an independent risk factor in the development of an inflammatory process leading to scaring of the uterine tubes in women and thereby causing infertility.
INTRODUCTION
Chlamydia infections are now reported to be the most prevalent and among the most damaging of sexually transmitted diseases worldwide (Falk et al., 2005) . Its manifestations are well acknowledged in women in whom it is responsible for the majority of cases of salpingitis (Moller and Mardh, 1980; Cohen et al., 2005) and pelvic inflammatory disease and thus accounts for a large number of cases of female factor infertility (Bjerke and Purvis, 1992; Eggert-Kruse et al., 1997) . More than 70% of women with signs of tubal damage have circulating antibodies C. trachomatis compared to none in a group of controls with normal fallopian tubes (Moore et al., 1992) reported a 64% incidence of Chlamydial antibodies in women with residual inflammatory admexal lesions, compared to 28% in women with normal adnexae. The implication is that the organism has a predilection the female may also have relevance to its pathological significance in the male.
MATERIALS AND METHODS
A total of 213 sera were obtained from women undergoing Invitrofertilzation/Human Research Reproduction Programme treatment at University of Benin Teaching Hospital from June 2007 to October 2008. All the women had hysterosalpinogram (HSG) as part of their infertility investigations. Those female patients with HSG report suggesting tubal factor infertility or occlusion were recruited into this study when they began the first IVF treatment. Semen analysis was carried out according to WHO criteria's of 1999. The semen samples were collected by masturbation after at least 3-5days abstinences.
Semen volume, concentration of spermatozoa, the percentage motility, morphology and vitality were determined. Base on the routine investigations described the couples were categorized into various groups according to possible causes of infertility. The laboratory employed a comprehensive internal quality control programmed for semen analysis based on World Health Organization's 10 th Semenology and Cervical Cytology workshop 2008 of which the author of this study was a participant.
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Seroanalysis of Chlamydia trachomatis
A 3-4 mL of blood sample was collected from each female patient who was allowed to clot to aspirate the serum for the detection of the antibody to C. trachomatis using the Immunocomb C. trachomatis IgG test which is an indirect solid. Phases Enzyme Immuno Absorbent (EIA) in line with WHO 1999 guidelines for the laboratory diagnosis of C. trachomatis infection with a performance characteristic of 95% sensitivity and 90% specificity.
RESULTS
A total of 69 (32.4%) out of the 213 were seropositive for the antibody to C. trachomatis. Tubal factor infertile women had 40 (18.8%), women with unexplained infertility with patent tubes 19 (8.9%) and women with infertile male partners 10 (4.9%) ( Table 2 ). Using the Chi-square there was significant correlation between the seropositivity of C. trachomatis and women with tubal factor infertility p<0.05. There was no age bias in the seroevidence of the organism in this study as the age groups were affected (Table 1) . 
DISCUSSION
Since antibodies to C. trachomatis were found in female patients with tubal factor infertility, this study suggests that Chlamydia is involved in other pathogenesis of Pelvic Inflammatory Diseases (PID) which may cause infertility due to compromised function of the uterine tubes. An earlier study Gump et al., (1993) supports this implication because the presence of C. trachomatis was detected in patient with cervicitis and adnexitis. This study recorded a total seropositive rate of 32.4% out of 213 investigated serologically. Female patients with tubal factor infertility contributed 18.8% followed by 8.9% from female with unexplained infertility (patent tube) and 4.9% from women with infertile male partners. Seropositivity of C. trachomatis was expected to dominate in patients with tubal factor infertility based on the result of previous work (Gump et al., 1993 , Eggertkruse et al., 1997 . C. trachomatis is a common cause of tubal factor infertility. Its manifestation is well acknowledged in women in whom it is responsible for majority of cases of salpinigitis and Pelvic inflammatory disease (Wang et al., 1997) and this account for a range number of cases of female factor infertility (Moore et al., 1992) more than 70% of women with signs of tubal damage have circulating antibodies to C. trachomatis compared to none in a group of controls with normal fallopian tubes (Paavonen, 1996) . This assertion is also similar to the findings in this study where women with tubal factor infertility recorded 18.8% compared to 8.9%.of women with normal fallopian or patent tubes obtained in this study. Similarly, Bjerke and Purvis (1992) reported 64% incidence of Chlamydia antibodies in women with residual inflammatory adnexal lesions, compared to 28% in women with normal adnexal. The implications is that the organism has a predilection for inducing inflammatory changes of the deep Pelvic organs in female. This may also have relevance to its pathological significance in the male.
In this study, there is an indication that a high degree of transmission of C. trachomatis occurs between infertile partner without either of them registering symptoms. Sera listed in this work were not derived from patients with acute disease. The female patients had no symptoms of Pelvic inflammatory diseases when they visited the infertility clinic. Perhaps infection with C. trachomatis is primarily asymptomatic as suggested in an earlier study with sexually active men and women attending Sexually Transmitted Diseases clinic. Bjerke and Purvis (1992) had noted that 76% of the male partners of C. trachomatis seropositive female exhibited seroevidence of infection. As the pathological significance of C. trachomatis in the female is well documented overtime, such chronic infections in females may cause tubal or endometrial pathology. This presumably explains the higher incidence of active Chlamydia infection in the male partners of women with tubal pathology (Paavonen, 1996) .
CONCLUSIONS
In conclusion this study indicated and agreed with the hypothesis that C. trachomatis may be an independent risk factor in causing deep-seated tubal occlusion and pelvic inflammatory diseases in women thereby bringing about infertility.
